Molecular genetic tests for <i>JAK2</i> V617F, Exon12_ <i>JAK2</i> and <i>MPL</i> W515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasms
Marcos Tadeu dos Santos(Fleury S.A. (Brazil)), Edgar Gil Rizzatti(Fleury S.A. (Brazil)), Kozue Miyashiro(Fleury S.A. (Brazil)), Miguel Mitne‐Neto(Hospital Santa Paula), Maria de Lourdes Chauffaille(Fleury S.A. (Brazil))
Cited by 7
Related Papers
A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis
|The American Journal of Human Genetics|2004|990
Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients
|Human Molecular Genetics|2011|213
Different Donors Mesenchymal Stromal Cells Secretomes Reveal Heterogeneous Profile of Relevance for Therapeutic Use
|Stem Cells and Development|2016|65
The p.P56S mutation in the <i>VAPB</i> gene is not due to a single founder: the first European case
|Clinical Genetics|2010|61